Hematological complications in the newborn: focus on perinatal hemolytic disease

Authors

Keywords:

alloantibodies, hemolytic disease of the newborn, Exchange transfusion

Abstract

Introduction: Perinatal hemolytic disease is an immunological condition in which maternal antibodies cross the placenta and cause hemolysis in the fetus or newborn.

Objective: To present a case diagnosed with perinatal hemolytic disease with multiple alloimmunization.

Clinical Case: We present the case of a newborn with perinatal hemolytic disease due to the presence of two alloantibodies, anti-D and anti-Lewis. The mother, with a history of previous pregnancies and blood transfusion, showed a high titer of both antibodies during the third. trimester. The newborn required intensive phototherapy and exchange transfusion.

Conclusions: It is essential to conduct serological monitoring in pregnant women at risk of alloimmunization, as well as to have a multidisciplinary approach to prevent severe complications.

Author Biography

Anelys García Salgado, Hospital “Iván Portuondo”. Artemisa, Cuba.

Especialista de primer y segundo grado de hematología. Profesor asistente. Diplomado de anticoagulantes. Profesor de laboratorio clínico , genética y microbiología . Profesor de inmunohematología

References

1. Karanam A, Bandiya P. Hemolytic Disease of Newborn: Beyond Rh-D and ABO Incompatibility. Indian Pediatr [Internet]. 2021 [acceso: 14/04/2024]; 58 (8): 794-795. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34465666/

2. Tewari VV, Kumar A, Singhal A, Pillai N, Prakash A, Varghese J, et al. Evaluation of Rh-Hemolytic Disease in Neonates and Management with Early Intensive Phototherapy in the Neonatal Intensive Care Unit. J Trop Pediatr [Internet]. 2020 [acceso: 14/04/2024]; 66 (1):75-84. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31199484/

3. Insunza A, Behnke E, Carrillo J. Enfermedad hemolítica perinatal: manejo de la embarazada RhD negativo. Rev chil obstet ginecol [Internet]. 2011 [acceso: 14/04/2024]; 76 (3): 188-206. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S071775262011000300010

4. Gelbenegger G, Schoergenhofer C, Derhaschnig U, Buchtele N, Sillaber C, Fillitz M, et al. Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program. Blood Adv. 2020; 4 (6): 997–1005. DOI: https://10.1182/bloodadvances.2019001321

5. Soler Noda G, González Guldriz M, Forrellat Barrios M. Diagnóstico diferencial de las anemias hemolíticas. Rev Cubana Hematol Inmunol Hemoter. 2020 [acceso 25/01/2021];36(4): e1097. Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/1097

6. Barcellini W. Fattizzo B. How I treat warm autoinmune hemolytic anemia. Blood. 2021; 137 (10): 1283-94. DOI: https://10.1111/j.1365-2141.1991.tb04484.x

7. Yazdani R, Habibi S, Sharifi L, Azizi G, Abolhassani H, Olbrich P, et al. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification and management. J Investig Allergol Clin Immunol. 2020; 30 (1):14-34. DOI: https://10.18176/jiaci.0388

8. Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, Wolny-Rokicka E, Nowakowska E, Gil L. Autoimmune hemolytic anemia: current knowledge and perspectives. Immun Ageing. 2020; 17:38. DOI: https://10.1186/s12979-020-00208-7

9. Berentsen S. New insights in the pathogenesis and therapy of cold agglutinin mediated autoimmune hemolytic Anemia. Front Immunol. 2020; 11:590. DOI: https://10.3389/fimmu.2020.00590

10. Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2019; 41:100648. DOI: https://10.1016/j.blre.2019.100648 4

11. Jackson ME, Baker JM. Hemolytic Disease of the Fetus and Newborn: Historical and Current State. Clin Lab Med [Internet]. 2021 [acceso: 14/04/2024]; 41 (1): 133-151. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33494881/

12. Amezcua Manuel. Enfermeras omitidas por la historia. Index Enferm. [Internet] 2021[citado 2024 Sep 03];30(3): 277-278. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S113212962021000200027

13. Nourkami N, Geipel M, Meyberg G, Takacs Z, Meyer S. Hydrops fetalis with isolated massive ascites in a preterm neonate with rhesus disease. Wien Med Wochenschr [Internet]. 2022 [acceso: 14/04/2024]; 172 (13-14): 290291. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33738630/

14. Hyland CA, O'Brien H, Flower RL, Gardener GJ. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation. Transfus Apher Sci [Internet]. 2020 [acceso: 14/04/2024]; 59 (5): 102947. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33115620/

15. Tugcu AU, Ince DA, Turan O, Belen B, Olcay L, Ecevit A. Hemolytic anemia caused by non-D minor blood incompatibilities in a newborn. Pan Afr Med J [Internet]. 2019 [acceso: 14/04/2024]; 33: 262. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31692740/

Published

2025-02-12

How to Cite

1.
García Salgado A, Alvarez- Capote N, Martínez Lemus O, Rosquete Valiente A. Hematological complications in the newborn: focus on perinatal hemolytic disease. Invest Medicoquir [Internet]. 2025 Feb. 12 [cited 2025 Dec. 5];17(1):e930. Available from: https://revcimeq.sld.cu/index.php/imq/article/view/930

Issue

Section

Case presentation